journal article·2017-07

Core-shell microparticles for protein sequestration and controlled release of a protein-laden core

Torri E. Rinker, Brandon D. Philbrick, Johnna S. Temenoff

Acta Biomaterialia· Volume 56
Publisher page

Abstract

Development of multifunctional biomaterials that sequester, isolate, and redeliver cell-secreted proteins at a specific timepoint may be required to achieve the level of temporal control needed to more fully regulate tissue regeneration and repair. In response, we fabricated core-shell heparin-poly(ethylene-glycol) (PEG) microparticles (MPs) with a degradable PEG-based shell that can temporally control delivery of protein-laden heparin MPs. Core-shell MPs were fabricated via a re-emulsification technique and the number of heparin MPs per PEG-based shell could be tuned by varying the mass of heparin MPs in the precursor PEG phase. When heparin MPs were loaded with bone morphogenetic protein-2 (BMP-2) and then encapsulated into core-shell MPs, degradable core-shell MPs initiated similar C2C12 cell alkaline phosphatase (ALP) activity as the soluble control, while non-degradable core-shell MPs initiated a significantly lower response (85+19% vs. 9.0+4.8% of the soluble control, respectively). Similarly, when degradable core-shell MPs were formed and then loaded with BMP-2, they induced a ∼7-fold higher C2C12 ALP activity than the soluble control. As C2C12 ALP activity was enhanced by BMP-2, these studies indicated that degradable core-shell MPs were able to deliver a bioactive, BMP-2-laden heparin MP core. Overall, these dynamic core-shell MPs have the potential to sequester, isolate, and then redeliver proteins attached to a heparin core to initiate a cell response, which could be of great benefit to tissue regeneration applications requiring tight temporal control over protein presentation. Statement of significance Tissue repair requires temporally controlled presentation of potent proteins. Recently, biomaterial-mediated binding (sequestration) of cell-secreted proteins has emerged as a strategy to harness the regenerative potential of naturally produced proteins, but this strategy currently only allows immediate amplification and re-delivery of these signals. The multifunctional, dynamic core-shell heparin-PEG microparticles presented here overcome this limitation by sequestering proteins through a PEG-based shell onto a protein-protective heparin core, temporarily isolating bound proteins from the cellular microenvironment, and re-delivering proteins only after degradation of the PEG-based shell. Thus, these core-shell microparticles have potential to be a novel tool to harness and isolate proteins produced in the cellular environment and then control when proteins are re-introduced for the most effective tissue regeneration and repair.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Electrospun Nanofibers in Biomedical Applications · Advanced Drug Delivery Systems · Hydrogels: synthesis, properties, applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (53)

Show source-provided references
1. Moving from static to dynamic complexity in hydrogel design10.1038/ncomms2271 ↗
2. Interactions Between Heparan Sulfate and Proteins-Design and Functional Implications10.1016/S1937-6448(09)76003-4 ↗
3. Polymeric protein delivery systems10.1016/j.progpolymsci.2007.04.001 ↗
4. Complexity in biomaterials for tissue engineering10.1038/nmat2441 ↗
5. Emerging strategies for spatiotemporal control of stem cell fate and morphogenesis10.1016/j.tibtech.2012.11.001 ↗
6. Specific VEGF sequestering and release using peptide-functionalized hydrogel microspheres10.1016/j.biomaterials.2012.01.032 ↗
7. Supramolecular design of self-assembling nanofibers for cartilage regeneration10.1073/pnas.0906501107 ↗
8. Differentiation of mesenchymal stem cells in heparin-containing hydrogels via coculture with osteoblasts10.1007/s00441-011-1265-8 ↗
9. The effect of heparin-functionalized PEG hydrogels on three-dimensional human mesenchymal stem cell osteogenic differentiation10.1016/j.biomaterials.2006.08.033 ↗
10. Functional PEG-peptide hydrogels to modulate local inflammation induced by the pro-inflammatory cytokine TNFalpha10.1016/j.biomaterials.2009.05.083 ↗
11. Heparin desulfation modulates VEGF release and angiogenesis in diabetic wounds10.1016/j.jconrel.2015.10.028 ↗
12. Heparin-based hydrogels with tunable sulfation & degradation for anti-inflammatory small molecule delivery10.1039/C6BM00455E ↗
13. Hydrolysis and sulfation pattern effects on release of bioactive bone morphogenetic protein-2 from heparin-based microparticles10.1039/C5TB00933B ↗
14. Fabrication of core-shell microcapsules using PLGA and alginate for dual growth factor delivery system10.1016/j.jconrel.2010.07.103 ↗
15. Fabrication of core–shell microspheres using alginate and chitosan–polycaprolactone for controlled release of vascular endothelial growth factor10.1016/j.reactfunctpolym.2012.04.007 ↗
16. Design and characterization of core-shell mPEG-PLGA composite microparticles for development of cell-scaffold constructs10.1016/j.ejpb.2013.03.027 ↗
17. Fabrication and characterization of monodisperse PLGA-alginate core-shell microspheres with monodisperse size and homogeneous shells for controlled drug release10.1016/j.actbio.2013.03.022 ↗
18. Multifunctional core-shell nanoparticles: discovery of previously invisible biomarkers10.1021/ja207515j ↗
19. A novel biomarker harvesting nanotechnology identifies Bak as a candidate melanoma biomarker in serum10.1111/j.1600-0625.2010.01187.x ↗
20. Core-shell hydrogel particles harvest, concentrate and preserve labile low abundance biomarkers10.1371/journal.pone.0004763 ↗
21. Encapsulation of basic fibroblast growth factor by polyelectrolyte multilayer microcapsules and its controlled release for enhancing cell proliferation10.1021/bm3005879 ↗
22. Dual growth factor delivery using biocompatible core-shell microcapsules for angiogenesis10.1002/smll.201300427 ↗
23. Hydrogels in controlled release formulations: network design and mathematical modeling10.1016/j.addr.2006.09.004 ↗
24. Heparin-functionalized polymeric biomaterials in tissue engineering and drug delivery applications10.1016/j.actbio.2013.07.031 ↗
25. Heparin microparticle effects on presentation and bioactivity of bone morphogenetic protein-210.1016/j.biomaterials.2014.05.011 ↗
26. Interactions of signaling proteins, growth factors and other proteins with heparan sulfate: mechanisms and mysteries10.3109/03008207.2015.1045066 ↗
27. An essential heparin-binding domain in the fibroblast growth factor receptor kinase10.1126/science.8456318 ↗
28. Effect of selective heparin desulfation on preservation of bone morphogenetic protein-2 bioactivity after thermal stress10.1021/bc500565x ↗
29. Effects of PEG hydrogel crosslinking density on protein diffusion and encapsulated islet survival and function10.1002/jbm.a.32134 ↗
30. Review: photopolymerizable and degradable biomaterials for tissue engineering applications10.1089/ten.2007.0093 ↗
31. Poly(ethylene glycol) hydrogels formed by conjugate addition with controllable swelling, degradation, and release of pharmaceutically active proteins10.1016/j.jconrel.2004.10.029 ↗
32. Photolithographic patterning of polyethylene glycol hydrogels10.1016/j.biomaterials.2005.11.045 ↗
33. Bone morphogenic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage10.1083/jcb.127.6.1755 ↗
34. Physical approaches to biomaterial design10.1038/nmat2344 ↗
35. The synthesis and assembly of polymeric microparticles using microfluidics10.1002/adma.200803386 ↗
36. Poly(ethylene glycol)-poly(lactic-co-glycolic acid) core–shell microspheres with enhanced controllability of drug encapsulation and release rate10.1080/09205063.2015.1058575 ↗
37. Microspheres for Drug Delivery
38. Development and characterization of microencapsulated microspheres10.1023/A:1018901619230 ↗
39. Microfluidic fabrication of bioactive microgels for rapid formation and enhanced differentiation of stem cell spheroids10.1016/j.actbio.2016.01.012 ↗
40. Microfluidic synthesis of biodegradable polyethylene-glycol microspheres for controlled delivery of proteins and DNA nanoparticles10.1021/ab500051v ↗
41. Microfluidic-based generation of size-controlled, biofunctionalized synthetic polymer microgels for cell encapsulation10.1002/adma.201304880 ↗
42. Adaptable poly(ethylene glycol) microspheres capable of mixed-mode degradation10.1016/j.actbio.2013.08.011 ↗
43. Functions of heparan sulfate proteoglycans in cell signaling during development10.1242/dev.01522 ↗
44. One-step fabrication of core–shell structured alginate–PLGA/PLLA microparticles as a novel drug delivery system for water soluble drugs10.1039/c3bm00175j ↗
45. Chondrogenic differentiation of mesenchymal stem cells: challenges and unfulfilled expectations10.1089/ten.teb.2013.0771 ↗
46. Regulatory factors and cell populations involved in skeletal muscle regeneration10.1002/jcp.22127 ↗
47. R&D Systems Incorporated, R&D Systems, , 2016 (accessed 08.10.16).
48. Water, solute and protein diffusion in physiologically responsive hydrogels of poly(methacrylic acid-g-ethylene glycol)10.1016/0142-9612(96)84941-6 ↗
49. Physicochemical foundations and structural design of hydrogels in medicine and biology10.1146/annurev.bioeng.2.1.9 ↗
50. Issues in long-term protein delivery using biodegradable microparticles10.1016/j.jconrel.2010.05.011 ↗
51. Material-based regulation of the myofibroblast phenotype10.1016/j.biomaterials.2007.04.005 ↗
52. Biomaterial strategies for controlling stem cell fate via morphogen sequestration10.1039/C5TB02575C ↗
53. Hydrophilic core-shell microspheres: a suitable support for controlled attachment of proteins and biomedical diagnostics10.1002/mabi.200500138 ↗